- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - https://eyedocnews.com -

Intravitreous Injections of Pegaptanib (Macugen) May Help Prevent Further Vision Loss From Central Retinal Vein Occlusion

Posted By Dr. Ari Weitzner On May 3, 2009 @ 12:08 am In Research,Retina | Comments Disabled

As recently reported in MedPage Today, a study published in the April 2009 issue of The Archives of Ophthalmology, researchers have found that intravitreous injections of pegaptanib (Macugen) may help prevent further vision loss from central retinal vein occlusion, but does little to reverse it.

Specifically, patients injected with the drug to treat macular edema from central retinal vein occlusion were no more likely to gain at least 15 letters on a visual acuity test than those who got sham injections (P=0.48 for the 0.3-mg dose and P=0.35 for the 1-mg dose).

On the other hand, substantially fewer pegaptanib-treated patients lost 15 or more letters in visual acuity compared with controls (9% at 0.3 mg and 6% at 1 mg versus 31% with sham, P=0.03 and P=0.01, respectively).

The drug was also associated with nonsignificant trends for less central retinal thickness and neovascularization.

Read [1] the full story on MedPage Today.


Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: https://eyedocnews.com

URL to article: https://eyedocnews.com/00957-intravitreous-injections-of-pegaptanib-macugen-may-help-prevent-further-vision-loss-from-central-retinal-vein-occlusion/

URLs in this post:

[1] Read: http://www.medpagetoday.com/Ophthalmology/GeneralOphthalmology/13802?utm_source=mSpoke&utm_medium=email&utm_campaign=DailyHeadlines&utm_content=GroupB&userid=212514&impressionId=1240193353333

Copyright © 2008 Eye Doc Talk. All rights reserved.